Literature DB >> 11189723

Public health implications of emerging zoonoses.

F X Meslin1, K Stöhr, D Heymann.   

Abstract

Many new, emerging and re-emerging diseases of humans are caused by pathogens which originate from animals or products of animal origin. A wide variety of animal species, both domestic and wild, act as reservoirs for these pathogens, which may be viruses, bacteria or parasites. Given the extensive distribution of the animal species affected, the effective surveillance, prevention and control of zoonotic diseases pose a significant challenge. The authors describe the direct and indirect implications for public health of emerging zoonoses. Direct implications are defined as the consequences for human health in terms of morbidity and mortality. Indirect implications are defined as the effect of the influence of emerging zoonotic disease on two groups of people, namely: health professionals and the general public. Professional assessment of the importance of these diseases influences public health practices and structures, the identification of themes for research and allocation of resources at both national and international levels. The perception of the general public regarding the risks involved considerably influences policy-making in the health field. Extensive outbreaks of zoonotic disease are not uncommon, especially as the disease is often not recognised as zoonotic at the outset and may spread undetected for some time. However, in many instances, the direct impact on health of these new, emerging or re-emerging zoonoses has been small compared to that of other infectious diseases affecting humans. To illustrate the tremendous indirect impact of emerging zoonotic diseases on public health policy and structures and on public perception of health risks, the authors provide a number of examples, including that of the Ebola virus, avian influenza, monkeypox and bovine spongiform encephalopathy. Recent epidemics of these diseases have served as a reminder of the existence of infectious diseases and of the capacity of these diseases to occur unexpectedly in new locations and animal species. The need for greater international co-operation, better local, regional and global networks for communicable disease surveillance and pandemic planning is also illustrated by these examples. These diseases have contributed to the definition of new paradigms, especially relating to food safety policies and more generally to the protection of public health. Finally, the examples described emphasise the importance of intersectorial collaboration for disease containment, and of independence of sectorial interests and transparency when managing certain health risks.

Entities:  

Mesh:

Year:  2000        PMID: 11189723     DOI: 10.20506/rst.19.1.1214

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  16 in total

1.  Veterinary public health.

Authors:  Cameron Stewart; John Cowden; Jim McMenamin; Bill Reilly
Journal:  BMJ       Date:  2005-11-26

2.  Molecular evolution of the primate antiviral restriction factor tetherin.

Authors:  Jun Liu; Keping Chen; Jian-Hua Wang; Chiyu Zhang
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

3.  Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.

Authors:  Horacio Almanza; Carolina Cubillos; Iván Angulo; Francisco Mateos; José R Castón; Wim H M van der Poel; Jan Vinje; Juan Bárcena; Ignacio Mena
Journal:  J Clin Microbiol       Date:  2008-10-08       Impact factor: 5.948

4.  Surveillance for arboviral zoonoses in New Zealand birds.

Authors:  Daniel Tompkins; Cheryl Johansen; Richard Jakob-Hoff; David Pulford; Isabel Castro; Graham Mackereth
Journal:  Western Pac Surveill Response J       Date:  2013-11-06

5.  Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox.

Authors:  Huiyong Wei; Dan Huang; Jeff Fortman; Richard Wang; Linyun Shao; Zheng W Chen
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

6.  Epidemiological aspects of human brucellosis and leptospirosis outbreaks in Korea.

Authors:  Yangho Jang; Hyobi Kim; Hyung-Ae Bang; Myong-Jin Lee; Nong-Hun Che; Won-Chang Lee
Journal:  J Clin Med Res       Date:  2011-07-26

7.  Renewed global partnerships and redesigned roadmaps for rabies prevention and control.

Authors:  Tiziana Lembo; Michaël Attlan; Hervé Bourhy; Sarah Cleaveland; Peter Costa; Katinka de Balogh; Betty Dodet; Anthony R Fooks; Elly Hiby; Fernando Leanes; François-Xavier Meslin; Mary Elizabeth Miranda; Thomas Müller; Louis H Nel; Charles E Rupprecht; Noël Tordo; Abbigail Tumpey; Alexander Wandeler; Deborah J Briggs
Journal:  Vet Med Int       Date:  2011-06-01

8.  The Ebola outbreak in West Africa: a story of related public health challenges and a pointer to solutions to mitigate the inevitable next outbreak.

Authors:  Peter Nsubuga
Journal:  Pan Afr Med J       Date:  2014-09-22

9.  Human noroviruses in swine and cattle.

Authors:  Kirsten Mattison; Anu Shukla; Angela Cook; Frank Pollari; Robert Friendship; David Kelton; Sabah Bidawid; Jeffrey M Farber
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

10.  Prioritization of zoonotic diseases of public health significance in Nigeria using the one-health approach.

Authors:  Chikwe Ihekweazu; Charles Akataobi Michael; Patrick M Nguku; Ndadilnasiya Endie Waziri; Abdulrazaq Garba Habib; Mathew Muturi; Abayomi Olufemi; Asabe A Dzikwi-Emennaa; Muhammad Shakir Balogun; Tyakaray Ibrahim Visa; Mahmood Muazu Dalhat; Nnomzie Charles Atama; Chukwuma David Umeokonkwo; Gideon Mbrusa Mshelbwala; Columba Teru Vakuru; Junaidu Kabir; Emmanuel C Okolocha; Jarlath U Umoh; Babasola Olugasa; Olutayo Babalobi; Lami Lombin; Simeon Cadmus
Journal:  One Health       Date:  2021-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.